Sign up
Log in
A Look At Clarivate (CLVT) Valuation After New Intellectual Property Leadership And AI Growth Focus
Share
Listen to the news

Clarivate (CLVT) is back in focus after the company appointed former CPA Global chief Simon Webster to lead its Intellectual Property segment, a key business where Clarivate is emphasizing AI and recurring revenue.

See our latest analysis for Clarivate.

The leadership change arrives after a tough stretch for investors, with the share price down 14.39% over the past 30 days and the 1 year total shareholder return declining 46.40%. This points to fading momentum as Clarivate leans into AI driven IP products and new executive oversight.

If this shift in Clarivate's IP focus has caught your attention, it may be worth broadening your research into other AI related opportunities using the 31 AI small caps

With Clarivate shares down sharply over the past year, a last close of US$2.38, and the stock trading at a sizeable discount to some intrinsic value estimates and analyst targets, is pessimism overshooting reality or already reflecting future growth?

Most Popular Narrative: 43.5% Undervalued

Clarivate's fair value in the most widely followed narrative is set at $4.21, well above the last close at $2.38. This frames a sharp valuation gap for investors to unpack.

Clarivate (NYSE: CLVT) rarely commands headlines, yet it sits at the center of how innovation is protected, monetized, and defended. The company provides data, analytics, and workflow tools that support intellectual property management, scientific research, regulatory compliance, and legal decision-making. In a world where competitive advantage increasingly depends on knowledge ownership rather than physical assets, Clarivate’s role is becoming more strategic, even if it remains largely invisible.

Read the complete narrative.

Want to see why this narrative assigns a higher value than the market does right now? It leans heavily on recurring cash flows, margin repair, and a future earnings profile that looks very different from recent losses. Curious which revenue trend and profitability assumptions are doing most of the heavy lifting in that $4.21 figure? The full story sets out those levers in detail.

Result: Fair Value of $4.21 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this relies on execution that avoids further integration setbacks and assumes the share price slide, including the 46.4% 1 year decline, does not signal deeper structural issues.

Find out about the key risks to this Clarivate narrative.

Next Steps

With the stock under pressure and sentiment clearly mixed, it helps to check the underlying data yourself and decide how much risk fits your style. You can start with the 4 key rewards.

Looking for more investment ideas?

If Clarivate has you thinking more broadly about opportunities, do not stop here. Widen your search and let structured tools surface ideas you might otherwise miss.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.